MedPath

Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies

Not Applicable
Completed
Conditions
Prostate Cancer
Registration Number
NCT01827813
Lead Sponsor
TC Erciyes University
Brief Summary

OBJECTIVE To assessment the results of repeated saturation and 10-12 core biopsy protocols in patients with a negative initial biopsy but continued suspicion for prostate cancer MATERIALS AND METHOD Data of the patients who underwent prostate biopsy between June 2007 and June 2012 were retrospectively assessed. Patients with an abnormal digital examination findings and/or abnormal serum prostate specific antigen levels were biopsied. The indication for a repeated biopsy was determined as the continued suspicion for a malignancy after the initial benign biopsy result and/or a pathology result consistent with a high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation. Patients who underwent saturation and core 10-12 biopsies at repeated biopsies were compared. Statistical analyses were performed with Shapiro-Wilk test and Mann- Whitney U test. A p value less than 0.05 was accepted as statistically significant.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
74
Inclusion Criteria
  1. Abnormal digital examination
  2. High serum prostate specific antigen (PSA) level.
  3. The continued suspicion for a malignancy after the initial benign biopsy result and/or a pathology result consistent with a high-grade prostatic intraepithelial neoplasia (HGPIN) or atypical small acinar proliferation (ASAP).
Exclusion Criteria
  1. Patients with coagulopathies
  2. Patients with unsuitable general conditions for prostate biopsy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Detection rate of prostate cancer.At least two months

Prostate cancer detection rate after saturation and repeated 10-12 core prostate biopsy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Urology, Ercieys University, Faculty Of Medicine,

🇹🇷

Kayseri, Turkey

Department of Urology, Ercieys University, Faculty Of Medicine,
🇹🇷Kayseri, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.